Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa
NCT03158662 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2017-08-24
Summary
This survey intends to collect information on key aspects of life with epidermolysis bullosa (EB), including diagnostic journey, treatment, management, daily living challenges, and overall psycho-social, socio-economic, academic and family impact.
Objectives:
* To understand the unmet needs for people living with EB in the US
* To assess the differences/similarities in the management/treatment of EB patients (including wound care, symptom management and other issues)
* To assess the EB patients' and caregivers' perceptions of current management/treatment
* To assess the challenges and the burden of daily living with EB
* To understand EB diagnostic journey (the time to diagnosis and by what type of healthcare provider)
* To identify professional disciplines involved in the diagnosis and management of EB
* To understand the psycho-social, socio-economic, academic, and family impact of EB
Conditions
- Epidermolysis Bullosa
Interventions
- OTHER
-
Survey
Survey Study
Sponsors & Collaborators
-
Amicus Therapeutics
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-02
- Primary Completion
- 2017-06-30
- Completion
- 2017-06-30
Countries
- United States
Study Locations
More Related Trials
-
Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis Bullosa
NCT02090283 ·Status: TERMINATED ·Phase: PHASE2
-
ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa
NCT02384460 ·Status: COMPLETED ·Phase: PHASE3
-
Computational Drug Repurposing for All EBS Cases
NCT03269474 ·Status: RECRUITING
-
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT01019148 ·Status: RECRUITING
-
A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa
NCT06917690 ·Status: RECRUITING ·Phase: PHASE3
-
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
NCT03016715 ·Status: UNKNOWN ·Phase: PHASE2
-
Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
NCT01033552 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
NCT01538862 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa
NCT03529877 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Artificial Intelligence Patient App for RDEB SCCs
NCT05843994 ·Status: ACTIVE_NOT_RECRUITING
-
A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
NCT04213703 ·Status: WITHDRAWN
-
Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT00904163 ·Status: COMPLETED
-
Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa
NCT07230223 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
NCT06423573 ·Status: RECRUITING
-
A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB
NCT05708677 ·Status: ENROLLING_BY_INVITATION
-
Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT01874769 ·Status: COMPLETED
-
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
NCT02960997 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa
NCT03578029 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of Complex Care Training of Hereditary Epidermolysis Bullosa on Caregiver Burden (FIREB)
NCT05248503 ·Status: COMPLETED
-
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT03392909 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
NCT06177353 ·Status: RECRUITING
-
Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa
NCT04217538 ·Status: COMPLETED
-
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
NCT05838092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
NCT05529134 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa
NCT04599881 ·Status: COMPLETED ·Phase: PHASE2